- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Monoamine Theory in Depression: Implications for Disease & Treatment

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Monoamine Theory in Depression: Implications for Disease & Treatment
This is a Virtual Event for PsychU members in DC, Maryland, North Carolina, South Carolina, and Virginia.
In this virtual learning event, learn about the foundational aspects of the monoamine theory for depression. Follow along as the presenters describe the neurobiological pathways of specific monoamines and their potential roles in emotional behaviors. After a discussion on the monoamine imbalance theory, the current treatment paradigms and neurological theories behind those paradigms will be discussed.
Featuring
-
Miranda Fisher, PhD
Medical Science Liaison
-
Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS
-
Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs
Speakers Miranda Fisher, PhD; Dennis Sholler, PhD; and Amica Simmons-Yon, PharmD, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.